Cardinal Health Inc. stock falls 1.36% amid weak market session

8 articles · Updated · MarketWatch · Apr 29

Shares closed at $202.82 on Wednesday, snapping a two-day winning streak and finishing 13.18% below the 52-week high of $233.60 set on March 2.
Cardinal Health underperformed major competitors, as Amazon, UnitedHealth Group, and CVS Health all posted gains during the session.
Trading volume matched its 50-day average at 1.7 million shares, reflecting continued investor activity despite the market downturn.

With Amazon gaining, is Cardinal Health's traditional distribution model strong enough to defend its market share?

Is Cardinal Health's stock truly undervalued, or does its high P/E ratio signal a hidden risk for investors?

How will Cardinal Health's big bet on cancer-fighting isotopes reshape its future growth and profitability?

Will tomorrow's earnings report confirm bullish forecasts, or will it reveal cracks from supply chain pressures?

Can the pharma supply chain withstand rising global tensions and new US tariffs without hurting consumers?